Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences received a disclosure from Mr. Samar Babubhai Patel, a member of the Promoter Group, regarding the transmission of 10,000 equity shares. The shares were transferred from Late Jasodaben Babubhai Patel (also a Promoter Group member) to Mr. Samar Patel due to transmission (inheritance). The acquisition was completed off-market on May 22, 2026. Post-transmission, Mr. Samar Patel holds 10,000 equity shares representing a negligible 0.00% of total shareholding. The disclosure was submitted on May 25, 2026, and the company secretary Dhaval N. Soni filed it on May 26, 2026.
This is a routine administrative transfer of shares within the promoter family due to inheritance. The volume involved (10,000 shares at 0.00% holding) is negligible and has no material impact on the company's shareholding structure or stock price.